Clinical Trial Update: Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and efficacy of an intravenous loading dose of ibandronate in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Boniva (ibandronate)

Snippet

Sponsor: University of Turku | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN